Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

Fingolimod And Cladribine: Two New Oral Substances Show Promising Results In Current Clinical Trials For MS Therapy
The results of current clinical trials on new substances for MS therapy are among the new research findings that are being discussed with particular interest at the ENS meeting. Professor Comi is part of an international research team presenting the latest results of a study involving the orally administered drug fingolimod that is still in the clinical trial state and yet to be approved. An earlier study showed that oral fingolimod reduced the annualizied relapse rate in MS patients by more than 50 percent versus placebo.
generic viagra online
GlaxoSmithKline And Genmab Announce Top-line Results For Ofatumumab In Rheumatoid Arthritis
GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced preliminary top-line results from a Phase III study of ofatumumab administered intravenously for the treatment of rheumatoid arthritis (RA) in patients who had an inadequate response to methotrexate. The study met the primary endpoint, ACR20 at 24 weeks, which indicates a 20 percent or greater improvement in the number of swollen and tender joints, as well as improvements in other disease-activity measures.
News of the day
Clues To How Adrenal Cancer Forms
At the ends of chromosome are special pieces of DNA called telomeres. Think of it as the little tip that caps off a shoelace. The telomeres send signals to the cells to let them know it"s the end point, not a break that should be repaired.
Oncology

General Medical Council Announces Launch Date For Doctors' Licences, UK

The GMC has announced the launch date of a milestone in medical regulation. From 16 November, all doctors will need a licence in order to practise medicine in the UK. Currently, to practise medicine in the UK, a doctor has to be registered with the GMC. But from 16 November, all doctors will need a licence in addition to their GMC registration to undertake any form of medical practice in the UK, including, but not limited to, writing prescriptions, holding a post as a doctor in the NHS, and signing death and cremation certificates. Since 20 April 2009, the GMC has been contacting all doctors on its register to find out whether they wish to take a licence. Some doctors, such as academics or researchers, won"t need a licence to practise and are therefore choosing to hold registration without a licence. GMC Chair Professor Peter Rubin said: "We have received a good response to the licensing campaign, having asked 225,000 doctors whether they want a licence to practise. So far, almost 50% of doctors have responded, with the vast majority choosing to take a licence. "The introduction of the licence is the first step towards a new system called revalidation, the process through which doctors will be asked periodically to demonstrate that they are up to date and fit to practise in the job they do. "Licensing is a major milestone. The next stage is to implement revalidation. Once we have the results back from the pilots we will be in a position to draw together a more coherent revalidation timetable." The GMC has produced a guide, evalidation: Information for Doctors and Frequently Asked Questions, which aims to answer doctors" queries about revalidation. The guide can be accessed at http://www.gmc-uk.org/revalidation General Medical Council


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009